PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 182 participants.

Also called NCT07741253

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 182 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07741253
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07741253. Randomized; single masking; primary purpose treatment. Start 2026-10-25 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PRECISE-AFMR I: Transcatheter Mitral Valve Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation in Patients at High Surgical Risk
Acronym
PRECISE-AFMR I
Condition
Atrial Functional
Condition
Mitral Regurgitation (MR)
Intervention (Device)
Transcatheter Edge-to-Edge Repair
Lead sponsor
China National Center for Cardiovascular Diseases (class: other government)
Collaborator
Chinese Academy of Medical Sciences, Fuwai Hospital (class: other)

Record details

Record id
cardio:ct-nct07741253
Content hash
a61425dc565232e850902c8d60ca03974469096cf4b1f9d098e8d9ee2377af53